CDK8 Antikörper (C-Term)
Kurzübersicht für CDK8 Antikörper (C-Term) (ABIN926004)
Target
Alle CDK8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Hund, Zebrafisch (Brachydanio rerio), Frosch, Huhn
-
Immunogen
- CDK8 antibody was raised in rabbit using the C terminal of CDK8 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CDK8 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this CDK8 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CDK8 (Cyclin-Dependent Kinase 8 (CDK8))
-
Andere Bezeichnung
- CDK8
-
Hintergrund
- The protein encoded by CDK8 is a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are highly similar to the gene products of Saccharomyces cerevisiae cdc28, and Schizosaccharomyces pombe cdc2, and are known to be important regulators of cell cycle progression. This kinase and its regulatory subunit cyclin C are components of the RNA polymerase II holoenzyme complex, which phosphorylates the carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II. This kinase has also been shown to regulate transcription by targeting the CDK7/cyclin H subunits of the general transcription initiation factor IIH (TFIIH), thus providing a link between the 'Mediator-like' protein complexes and the basal transcription machinery. Synonyms: Polyclonal CDK8 antibody, Anti-CDK8 antibody, cyclin-dependent kinase 8 antibody.
-
Pathways
- Zellzyklus, Regulation of Lipid Metabolism by PPARalpha
Target
-